Beyond the K-hole: A 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug

Addiction

Volumn 99, Issue 11, 2004, Pages 1450-1461

  Morgan, Celia J A ^a   Monaghan, Lisa ^a   Curran, H Valerie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic effects; Drug abuse; Episodic memory; Ketamine; NMDA receptor antagonist; Semantic memory

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISSOCIATIVE DISORDER; DRUG ABUSE; DRUG WITHDRAWAL; EPISODIC MEMORY DISORDER; FEMALE; FUNCTIONAL DISEASE; HUMAN; LONGITUDINAL STUDY; MALE; MEMORY DISORDER; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; PERCEPTION DISORDER; RECREATIONAL DRUG USE; SCHIZOTYPAL PERSONALITY DISORDER; SEMANTIC MEMORY DISORDER; WORKING MEMORY;

ADULT; ANALGESICS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KETAMINE; LANGUAGE DISORDERS; LONGITUDINAL STUDIES; MALE; MEMORY DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 8544279622     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00879.x     Document Type: Article

References (47)

1. Adler, C. M., Goldberg, T. E., Malhotra, A. K. & Breier, A. (1998) Effects of ketamine on thought disorder, working memory and semantic memory in healthy volunteers. Biological Psychiatry, 43, 811-816.
2. Allen, H. A., Liddle, P. F. & Frith, C. D. (1993) Negative features, retrieval processes and verbal fluency in schizophrenia. British Journal of Psychiatry, 163, 769-775.
3. Allen, R. M. & Young, S. J. (1978) Phencyclidine induced psychosis. American Journal of Psychiatry. 135, 1081-1084.
4. Arango, C., Bartko, J. J., Gold, J. M. & Buchanan, R. W. (1999) Prediction of neuropsychological performance by neurological signs in schizophrenia. American Journal of Psychiatry, 156, 1349-1357.
5. Baddeley, A. D., Emslie, H. & Nimmo-Smith, I., (1992) The Speed and Capacity of Language Processing (SCOLP) Test. Bury St Edmonds: Thames Valley Test Company.
6. Baddeley, A., Emslie, H. & Nimmo-Smith, I. (1993) The spot the word test: a robust estimate of verbal intelligence based on lexical decision. British Journal of Clinical Psychology, 32, 55-65.
7. Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S. & Krystal, J. H. (2000) Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47, 351-354.
8. Bernstein, H. G., Becker, A., Keilhoff, G., Spilker, C., Gorczyca, W. A., Braunewell, K. H. & Grecksch, G. (2003) Brain region-specific changes in the expression of calcium sensor proteins after repeated applications of ketamine to rats. Neuroscience Letters, 339, 95-98.
9. Bond, A. J. & Lader, M. H. (1974) The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology, 47, 211-218.
10. Bremner, J. D., Krystal, J. D., Putman, F. W., Southwick, S. M., Marmar, C., Charney, D. S. & Mazure, C. M. (1998) Measurement of dissociative states with the Clinician Administered Dissociative States Scale (CADDS). Journal of Traumatic Stress, 11, 125-136.
11. Carroll, M. E. (1990) PCP and hallucinogens. Advances in Alcohol and Substance Abuse, 9, 167-190.
12. Cosgrove, J. & Newell, T. G. (1991) Recovery of neuropsychological functions during reduction in use of phencyclidine. Journal of Clinical Psychology, 47, 159-169.
13. Curran, H. V. (2000) Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology, 42, 34-41.
14. Curran, H. V. & Monaghan, L. (2001) In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction, 96, 749-760.
15. Curran, H. V. & Morgan, C. J. A. (2000) Cognitive, dissociative and psychotogenic effects of ketamine on recreational users on the night of drug use and 3 days later. Addiction, 95, 575-590.
16. Curran, H. V. & Weingartner, H. (2002) Psychopharmacology and memory. In: Baddeley, A., Wilson, B. & Kopelman, M., eds. Handbook of Memory Disorders, pp. 124-141. Chichester: John Wiley and Sons.
17. Danion, J. M., Rizzo, L. & Bruant, A. (1999) Functional mechanisms underlying impaired recognition memory and conscious awareness in patients with schizophrenia. Archives of General Psychiatry. 56, 639-644.
18. DAWN (2003) Emergency Department Trends from the Drug Abuse Warning Network DAWN: Final Estimates 1995-2002. DHHS Publication no. (SMA) 03-3780. Rockville, MD: Department of Health and Human Services.
19. Domino, E. F., Chodoff, P. & Corssen, G. (1965) Pharmacologic effects of CI-581, a new dissociative anaesthetic, in man. Clinical and Pharmacological Therapeutics, 6, 279-291.
20. Ellison, G. (1995) The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilipine as both behavioural and anatomical models of the dementias. Brain Research Reviews, 20, 250-267.
21. Goodman, A. & Gilman, A. (2001) The Pharmacological Basis of Therapeutics, 10th edn. New York: McGraw-Hill.
22. Hertzman, M., Reba, R. C. & Kotlyarove, E. V. (2002) Single photon emission computerised tomography in phencyclidine and related drug abuse. American Journal of Psychiatry, 147, 255-256.
23. Hetem, L. A. B., Danion, J. M., Diemunsch, P. & Brandt, C. (2000) Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology, 152, 283-288.
24. Jenstch, J. D., Roth, R. H. & Taylor, J. R. (2000) Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity. Biological Psychiatry, 48, 415-424.
25. Jentsch, J. D., Redmond, D. E., Elsworth, J. D., Taylor, J. R. Youngren, K. D. & Roth, R. H. (1997) Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science, 277, 953-955.
26. Jentsch, J. D. & Roth, R. H. (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 30, 201-225.
27. Krystal, J. H. Bennett, A. Abi-Saab, D. Beiger, A. Karper, L. P. D'Souza, D. C. Lipschitz, D. Abi-Dargham, A. & Charney, D. S. (2000) Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biological Psychiatry, 47, 137-143.
28. Krystal, J. H. Karper, L. P. Seibyl, J. P. Freeman, G. K. Delaney, R. Bremner, J. D. Heninger, G. R. Bowers, M. B. & Charney, D. S. (1994) Subanesthetic effects of the non-competitive NMDA-antagonist, ketamine, in humans, Archives of General Psychiatry, 51, 199-214.
29. Malhotra, A. K. Pinals, D. A. Weingartner, H. Sirocco, K. Missar, C. D. Pickar, D. & Breier, A. (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology, 14, 301-307.
30. Mixmag (2002) The Mixmag Drug Survey 2001: the World's Biggest Drug Survey, pp. 84-103. London, UK: EMAP.
31. Moghaddam, B., Adams, B., Verma, A. & Daly, D. (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Journal of Neuroscience, 17, 2921-2927.
32. Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L. & Curran, H. V. (2004a) Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology, 29, 208-218.
33. Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L. & Curran, H. V. (2004b) Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study. Psychopharmacology, 172, 298-308.
34. Morgan, C. J. A., Ricelli, M., Maitland, C. H. & Curran, H. V. (2004c) Long-term effects of ketamine abuse: evidence for a persisting impairment of source memory in recreational users. Drug and Alcohol Dependence, 75, 301-308.
35. Morizot, J. & Le Blanc, M. (2003) Continuity and change in personality traits from adolsecence to mid-life: a 25 year longitudinal study comparing representative and adjudicated men. Journal of Personality, 71, 705-755.
36. Nestor, P. J., Graham, K. S., Bozeat, S., Simons, J. & Hodges, J. R. (2002) Memory consolidation and the hippocampus: further evidence from studies of autobiographical memory in semantic dementia and frontal variant frontotemporal dementia. Neuropsychologia, 40, 633-654.
37. Newcomer, J. W., Farber, N. B., Jevtovic-Todorovic, V., Selke, G., Melson, A. K., Hershey, T., Craft, S. & Olney, J. W. (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology, 20, 106-118.
38. Olney, J., Labruyere, J. & Price, M. T. (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244, 1360-1362.
39. Olney, J., Labruyere, J., Wang, G., Wozniak, D., Price, M. T. & Sesma, M. (1991) NMDA antagonist neurotoxicity. Mechanism and Prevention Science, 254, 1515-1518.
40. Olney, J. W., Newcomer, J. W. & Farber, N. B. (1999) NMDA receptor hypofunction model of schizophrenia. Journal of Psychiatric Research, 33, 523-533.
41. Rainey, J. M. & Crowder, M. K. (1974) (Letter) Ketamine or phencyclidine? JAMA, 230, 824.
42. Siegel, R. K. (1978) Phencyclidine and ketamine intoxication. A Study of Recreational Users. In: Peterson, R. C. & Stillman, R., eds. Phencyclidine Abuse: An Appraisal, pp. 119-140. National Institute on Drug Abuse Research Monograph. Rockville. MD: NIDA.
43. Solowij, N., Hall, W. & Lee, N. (1992) Recreational MDMA use in Sydney: a profile of 'Ecstasy' users and their experience with the drug. British Journal of Addiction, 87, 1161-1172.
44. Wilson, B., Cockburn, J. & Baddeley, A. (1985) The Rivermead Behavioural Memory Test. Bury St Edmunds: Thames Valley Test Company.
45. Wu, J. C., Buchsbaum, M. S. & Bunney, B. S. (1991) Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. Japanese Journal of Psychopharmacology, 11, 47-48.
46. Zakzanis, K. K., Leach, L. & Kaplan, E. (1998) On the nature and pattern of neurocognitive functioning in major depressive disorder. Neuropsychiatry, Neuropsychology and Behavioural Neurology, 11, 111-119.
47. Zakzanis, K. K. & Young, D. A. (2001) Memory impairment in abstinent MDMA ('Ecstasy') users: a longitudinal investigation. Neurology, 56, 969.